Yanina Grant-Huerta, Chief Accounting Officer at Atara Biotherapeutics, Inc. (ATRA), sold 2,104 shares at $5.08 ($11K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Open-market sale of $11k ATRA by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.08 | 24 | $122 | 1.1% |
| 2 | $5.08 | 100 | $508 | 4.8% |
| 3 | $5.08 | 377 | $2K | 17.9% |
| 4 | $5.08 | 1,603 | $8K | 76.2% |
| Total | $5.08 avg | 2,104 | $11K | 100% |
| Filing → |
| ATRA | SELL | 2025-08-20 | $21K | — | Filing → |
| ATRA | SELL | 2025-05-20 | $15K | — | Filing → |